As part of a $10 million investment in 2024, new production lines for needles and syringes have been installed at BD’s plants in Connecticut and Nebraska, with one line already operational, according to a Jan. 15 news release from the company.
BD is also investing $30 million in 2025 to expand IV catheter production at its Utah facility, following a $2 million investment in 2024 that increased output by 40 million IV catheters per year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
